Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Luveris
Active Ingredient: Lutropin alfa, rch 75IU
Dosage Form: Powder for injection
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited, t/a Healthcare Logistics
Manufacturer: Laboratoires Serono SA, Aubonne, Switzerland
Note: This consent is valid for two years from 13 May 2006.
Product: Taxotere
Active Ingredient: Docetaxel trihydrate 40mg/mL
Dosage Form: Solution for concentrate for infusion
New Zealand Sponsor: Aventis Pharma Limited
Manufacturers: Aventis Pharma, Rainham, Dagenham, Essex, United Kingdom
Aventis Principes Actifs Pharmaceutiques,Vitry-Sur-Seine, France
Note: This consent is valid for two years from 23 May 2006.
Dated this 5th day of May 2006.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).